What does InflaRx N.V. do?

InflaRx N.V. is a public company in the Pharmaceutical Preparations industry, incorporated in P7. It is registered with the SEC under CIK 0001708688 and trades on NASDAQ under the ticker IFRX.

How many SEC filings has InflaRx N.V. made?

InflaRx N.V. has filed 263 documents with the SEC since 2017. These include annual reports (10-K), quarterly reports (10-Q), current event notices (8-K), and insider transaction disclosures (Form 4).

InflaRx N.V.

IFRX NASDAQ CIK: 0001708688 Pharmaceutical Preparations Inc. in P7

View on SEC.gov →

Overview All Filings Annual Quarterly Insiders

Recent Filings

All 263 filings →

Form	Description	Date
20-F	ANNUAL REPORT	Mar 20, 2026
6-K	REPORT OF FOREIGN PRIVATE ISSUER	Mar 19, 2026
3	—	Mar 18, 2026
3	—	Mar 18, 2026
3	—	Mar 18, 2026
3	—	Mar 18, 2026
3	—	Mar 18, 2026
3	—	Mar 18, 2026
3	—	Mar 18, 2026
3	—	Mar 18, 2026

Insider Transactions

View all →

No insider transactions loaded yet.

About This Profile

This page aggregates all publicly available SEC EDGAR data for InflaRx N.V.. Financial figures are sourced from XBRL-tagged 10-K annual reports. Insider transactions are sourced from Form 4 filings required within two business days of a transaction.

Key Financials

Financial data not yet loaded.

Details

CIK: 0001708688
Ticker: IFRX
Exchange: NASDAQ
Incorporated: P7
First Filing: 2017
Total Filings: 263

Pharmaceutical Preparations rankings →